State Initiatives to Control Medication Costs--Can Transparency Legislation Help?

N Engl J Med. 2016 Jun 16;374(24):2301-4. doi: 10.1056/NEJMp1605100.

Authors

Ameet Sarpatwari¹, Jerry Avorn¹, Aaron S Kesselheim¹

Affiliation

¹ From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.

PMID: 27305189
DOI: 10.1056/NEJMp1605100

No abstract available

MeSH terms

Cost Control
Drug Costs*
Drug Discovery / economics*
Drug Discovery / legislation & jurisprudence
Drug Industry / economics
Drug Industry / legislation & jurisprudence*
Government Regulation
Humans
Insurance, Health, Reimbursement / economics
Prescription Drugs / economics*
State Government*
United States

Substances

Prescription Drugs